Fred Moll, founder of surgical robotics firms Intuitive Surgical and Auris Health, participated in in the financing round, along with previous Auris investors.

Recalled heart devices often lack clinical testing, researchers found in a study published last week in the Annals of Internal Medicine. Heart devices account for one-third of Class I recalls, the ...

The Protecting Access to Medicare Act (PAMA) of 2014 tied laboratory payment rates to market data for diagnostic tests, resulting in three rounds of reimbursement cuts. ACLA and other industry groups ...

The FDA plans to move the assays from higher-risk class III devices to class II, making them eligible for the 510(k) pathway.

SYLKE® was developed by Dr. M. Mark Mofid, a faculty member of The Johns Hopkins School of Medicine and a practicing plastic surgeon for more than 20 years. Dissatisfied with outcomes, he conducted ...

Some people who use a Freestyle Libre 3 glucose sensor are facing delays getting their prescriptions filled. Abbott spokesperson Lindsy Delco said the delays are driven by strong demand for the Libre ...

BioBridges has been a trusted partner in the life sciences industry for more than 20 years. With the launch of its new ...

Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.

Siemens Healthineers will integrate its robotic X-ray imaging system with Medtronic’s spine surgery suite. Medtronic and Siemens Healthineers have partnered to expand access to pre- and post-operative ...